Paul Kedrosky

Dr. Paul Kedrosky is a former highly ranked sell-side technology equity analyst, and he currently runs a technology finance institute at the University of California, San Diego. He is also a venture partner with Ventures West, an institutional venture capital firm with more than $400 million under management.

Dr. Kedrosky writes a regular column for the National Post (in Canada) and contributes regularly to other publications, including The Wall Street Journal. He's also been featured on CNN, CNBC, NPR and many other radio and television outlets. He maintains a widely read blog called Infectious Greed.

Recent Articles By The Author

Stock Influx: Weekend Reading

Cash and bonds look even worse than usual, and equities still don't look awful, so it's easy to imagine a continuing influx of money into stocks.

Sizing Up QE2: Weekend Reading

The stock market's reaction to a second round of quantitative easing will depend on the program's size.

All Earnings: Weekend Reading

The stock market's focus next week will be on earnings, but investors will also watch currencies.

Mortgage Mess: Weekend Reading

The mortgage fraud saga will only grow louder next week, weighing down bank stocks.

Market Turning?: Weekend Reading

Major stock market indices rose this week, but it feels like things are turning as currency worries rise and weak news continues.